INMB
Inmune Bio, Inc.
+0.10 (+4.88%)2.15USD115K成交股數59.7M市值–本益比(近四季)1193.5股價營收比–營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | 50K+257% | – | – | – | 14K | 43K | 46K | 38K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | 3.6M | 4.9M | 5.8M | 7.6M | 7.4M | 10.1M | 7.1M | 8.7M | 6.0M | 4.1M | 4.1M |
| 銷售管理費用 | 2.3M | 2.2M | 2.5M | 2.3M | 2.3M | 2.1M | 2.2M | 2.8M | 2.3M | 2.6M | 2.3M | 2.3M |
| 營業利益 | −1.5M-85% | −5.8M-39% | −7.4M-40% | −24.6M+149% | −9.9M-10% | −9.5M+11% | −12.3M+92% | −9.9M+54% | −11.0M | −8.5M | −6.4M | −6.4M |
| 營業利益率 | – | – | – | – | -19,810.0% | – | – | – | -78,692.9% | -19,832.6% | -13,937.0% | -16,902.6% |
| 稅後淨利 | −1.3M-87% | −5.4M-41% | −6.5M-46% | −24.5M+151% | −9.7M-12% | −9.1M+7% | −12.1M+86% | −9.7M+49% | −11.0M | −8.6M | −6.5M | −6.5M |
| 淨利率 | – | – | – | – | -19,478.0% | – | – | – | -78,750.0% | -19,914.0% | -14,132.6% | -17,200.0% |
| 稀釋 EPS | -0.05-88% | -0.20-50% | -0.24-60% | -1.05+110% | -0.43-30% | -0.40-17% | -0.60+67% | -0.50+39% | -0.61 | -0.48 | -0.36 | -0.36 |
| 稀釋股數 | 26.7M | 26.6M | 26.6M | 23.3M | 22.5M | 19.9M | 20.2M | 19.3M | 18.0M | 18.0M | 17.9M | 17.9M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 18.4M | 21.4M | 27.7M | 33.4M | 19.3M | 20.9M | 33.6M | 31.1M | 26.0M | 41.8M | 47.8M | 51.0M |
| 應收帳款 | 4.4M | 479K | 1.7M | 1.6M | 1.3M | 1.2M | 1.1M | 3.1M | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 26.8M | 25.8M | 33.4M | 37.7M | 37.8M | 39.6M | 52.8M | 52.5M | 46.8M | 62.7M | 69.7M | 74.0M |
| 有息負債 | – | – | – | 15.0M | 15.0M | 15.0M | – | – | – | 12.5M | 15.0M | 15.0M |
| 總負債 | 6.5M | 6.2M | 8.0M | 8.8M | 8.1M | 7.5M | 14.1M | 15.4M | 17.8M | 18.0M | 19.1M | 18.7M |
| 股東權益 | 20.4M | 19.6M | 25.4M | 28.9M | 29.7M | 32.1M | 38.7M | 36.3M | 28.2M | 43.9M | 50.7M | 55.3M |
| 負債比 | 24.1% | 24.0% | 23.9% | 23.4% | 21.5% | 18.9% | 26.7% | 29.3% | 38.0% | 28.7% | 27.3% | 25.3% |
| 淨現金(現金 − 有息負債) | – | – | – | 18.4M | 4.3M | 5.9M | – | – | – | 29.3M | 32.8M | 36.0M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.4M | – | – | −6.8M-9% | – | – | – | −7.5M | – | – | −1.1M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 50K | +257.1% | −46.0M | -92,000.0% | -1.86 | −23.6M |
| FY2024 | 14K | -91.0% | −42.0M | -300,000.0% | -2.11 | – |
| FY2023 | 155K | -58.6% | −30.0M | -19,354.8% | -1.67 | – |
| FY2022 | 374K | +106.6% | −27.3M | -7,299.2% | -1.52 | – |
| FY2021 | 181K | +1545.5% | −30.3M | -16,762.4% | -1.88 | – |
| FY2020 | 11K | – | −12.1M | -109,990.9% | -1.01 | – |
| FY2019 | – | – | −7.7M | –% | -0.75 | – |
| FY2018 | 0.00 | – | −12.4M | –% | -1.43 | – |